Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)

Shenzhen YHLO Biotech Revenue

Shenzhen YHLO Biotech had revenue of 490.14M CNY in the quarter ending June 30, 2026, with 25.47% growth. This brings the company's total for the last twelve months to 1.89B, up 1.62% year-over-year. In the year 2025, Shenzhen YHLO Biotech had annual revenue of 1.81B, down -9.99%. That makes Shenzhen YHLO Biotech the 14,920th largest company in the world by revenue and 2,671st in China.

• Revenue (ttm): 1.89B
• Revenue Growth: +1.62%
• P/S Ratio: 3.08
• Revenue / Employee: 1.12M
• Employees: 1,689
• Market Cap: 5.83B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 1.45B 82.1%
• Overseas 315.75M 17.9%

Fiscal year ended Dec 31, 2025 See the full Shenzhen YHLO Biotech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.81B	-200.99M	-9.99%
Dec 31, 2024	2.01B	-41.48M	-2.02%
Dec 31, 2023	2.05B	-1.93B	-48.42%
Dec 31, 2022	3.98B	2.80B	237.95%
Dec 31, 2021	1.18B	178.89M	17.91%

Data Source: S&P Global Market Intelligence Last updated: Aug 26, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error